Literature DB >> 12193427

The emergence of resistant pneumococcal meningitis--implications for empiric therapy.

P McMaster1, P McIntyre, R Gilmour, L Gilbert, A Kakakios, C Mellis.   

Abstract

BACKGROUND: Following the emergence of penicillin and cephalosporin resistant pneumococcal meningitis in the United States, inclusion of vancomycin in empiric therapy for all suspected bacterial meningitis was recommended by the American Academy of Pediatrics. Few data are available to evaluate this policy. AIMS: To examine the management and clinical course in relation to antibiotic therapy of a large unselected cohort of children with pneumococcal meningitis in a geographic area where antibiotic resistance has recently increased.
METHODS: Retrospective review of all cases of pneumococcal meningitis in a defined population (Sydney, Australia), 1994-99.
RESULTS: A total of 104 cases without predisposing illnesses were identified; timing of lumbar puncture (LP) was known in 103. Resistance to penicillin increased from 0 to 20% over the study period. Only 57 (55%) had an early LP (prior to parenteral antibiotics); 55 (96%) had organisms on Gram stain. Severe disease (intensive care admission or death) increased significantly from 57 cases with early LP (28%) to 33 with delayed LP (42%) to 13 with no LP (62%). Evidence of pneumococcal infection was available within 24 hours in 85% of those with delayed or no LP. Outcome was not related to empiric vancomycin use, which increased from 5% prior to 1998 to 48% in 1999.
CONCLUSION: LP is frequently delayed in pneumococcal meningitis. Based on disease severity, empiric vancomycin is most justified when LP is deferred. If an early LP is done, vancomycin can be withheld if Gram positive diplococci are not seen.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12193427      PMCID: PMC1719212          DOI: 10.1136/adc.87.3.207

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  12 in total

1.  [Therapeutic failure with high-dose cefotaxime in pneumococcal meningitis].

Authors:  M L Michaus; L Pérez-Díaz; M de Pablos; M J Lezaun; J López-Bayón
Journal:  Enferm Infecc Microbiol Clin       Date:  1997-05       Impact factor: 1.731

2.  Failure of cefotaxime treatment in a patient with penicillin-resistant pneumococcal meningitis and confirmation of nosocomial spread by random amplified polymorphic DNA analysis.

Authors:  J Raymond; E Bingen; C Doit; N Brahimi; M Bergeret; J Badoual; D Gendrel
Journal:  Clin Infect Dis       Date:  1995-07       Impact factor: 9.079

Review 3.  Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae.

Authors:  M M París; O Ramilo; G H McCracken
Journal:  Antimicrob Agents Chemother       Date:  1995-10       Impact factor: 5.191

4.  Rapidly emerging antimicrobial resistances in Streptococcus pneumoniae in Australia. Pneumococcal Study Group.

Authors:  J D Turnidge; J M Bell; P J Collignon
Journal:  Med J Aust       Date:  1999-02-15       Impact factor: 7.738

5.  A review of the clinical presentation, laboratory features, antimicrobial therapy and outcome of 77 episodes of pneumococcal meningitis occurring in children and adults.

Authors:  B Kirkpatrick; D S Reeves; A P MacGowan
Journal:  J Infect       Date:  1994-09       Impact factor: 6.072

6.  Three-year multicenter surveillance of pneumococcal meningitis in children: clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use.

Authors:  M Arditi; E O Mason; J S Bradley; T Q Tan; W J Barson; G E Schutze; E R Wald; L B Givner; K S Kim; R Yogev; S L Kaplan
Journal:  Pediatrics       Date:  1998-11       Impact factor: 7.124

7.  Bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis.

Authors:  K P Klugman; I R Friedland; J S Bradley
Journal:  Antimicrob Agents Chemother       Date:  1995-09       Impact factor: 5.191

8.  Bacterial meningitis in older children.

Authors:  W A Bonadio; M Mannenbach; R Krippendorf
Journal:  Am J Dis Child       Date:  1990-04

9.  Appearance of resistance to beta-lactam antibiotics during therapy for Streptococcus pneumoniae meningitis.

Authors:  M Muñoz; E S Valderrabanos; E Diaz; J J Silva; J A Soult; P Infante; J D Lopez; A Garcia-Curiel
Journal:  J Pediatr       Date:  1995-07       Impact factor: 4.406

10.  Antibiotic therapy and acute outcome of meningitis due to Streptococcus pneumoniae considered intermediately susceptible to broad-spectrum cephalosporins.

Authors:  T Q Tan; G E Schutze; E O Mason; S L Kaplan
Journal:  Antimicrob Agents Chemother       Date:  1994-05       Impact factor: 5.191

View more
  5 in total

Review 1.  When to do a lumbar puncture.

Authors:  F A I Riordan; A J Cant
Journal:  Arch Dis Child       Date:  2002-09       Impact factor: 3.791

Review 2.  Diagnosis and treatment of bacterial meningitis.

Authors:  H El Bashir; M Laundy; R Booy
Journal:  Arch Dis Child       Date:  2003-07       Impact factor: 3.791

3.  A population based study of the impact of corticosteroid therapy and delayed diagnosis on the outcome of childhood pneumococcal meningitis.

Authors:  P B McIntyre; C R Macintyre; R Gilmour; H Wang
Journal:  Arch Dis Child       Date:  2005-04       Impact factor: 3.791

4.  Frequency Distribution of Antibiotic Therapy Intervention According to Lumbar Puncture Cerebrospinal Fluid Outcome in Hospitalized Children.

Authors:  Farzad Ferdosian; Alireza Eghbali Kheyrabadi; Zahra Nafei
Journal:  Maedica (Bucur)       Date:  2020-12

5.  In vitro evaluation of the antimicrobial activity of ceftaroline against cephalosporin-resistant isolates of Streptococcus pneumoniae.

Authors:  Lesley McGee; Donald Biek; Yigong Ge; Magderie Klugman; Mignon du Plessis; Anthony M Smith; Bernard Beall; Cynthia G Whitney; Keith P Klugman
Journal:  Antimicrob Agents Chemother       Date:  2008-11-17       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.